Published in Pure Appl Chem on January 01, 2009
Bioactive 5,6-dihydro-alpha-pyrone derivatives from Hyptis brevipes. J Nat Prod (2009) 1.48
Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae. J Antibiot (Tokyo) (2012) 1.24
Bioactive constituents of the stem bark of Mitrephora glabra. J Nat Prod (2009) 1.23
Cyclodepsipeptides, sesquiterpenoids, and other cytotoxic metabolites from the filamentous fungus Trichothecium sp. (MSX 51320). J Nat Prod (2011) 1.16
Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents. ACS Med Chem Lett (2012) 1.11
Peptaibols from two unidentified fungi of the order Hypocreales with cytotoxic, antibiotic, and anthelmintic activities. J Pept Sci (2012) 1.06
Cytotoxic and NF-κB inhibitory sesquiterpene lactones from Piptocoma rufescens. Tetrahedron (2012) 1.05
Bioactive constituents of Indigofera spicata. J Nat Prod (2013) 1.00
Peptaibols, tetramic acid derivatives, isocoumarins, and sesquiterpenes from a Bionectria sp. (MSX 47401). J Nat Prod (2013) 0.99
Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). J Nat Prod (2009) 0.97
The continuing search for antitumor agents from higher plants. Phytochem Lett (2010) 0.94
Isolation, structure elucidation, and biological evaluation of 16,23-epoxycucurbitacin constituents from Eleaocarpus chinensis. J Nat Prod (2012) 0.93
Nitrile-Containing Fischerindoles from the Cultured Cyanobacterium Fischerella sp. Tetrahedron (2012) 0.90
Revisiting the enniatins: a review of their isolation, biosynthesis, structure determination and biological activities. J Antibiot (Tokyo) (2012) 0.90
Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol (2015) 0.90
Proteasome-inhibitory and cytotoxic constituents of Garcinia lateriflora: absolute configuration of caged xanthones. Tetrahedron (2010) 0.89
Dereplication of macrocyclic trichothecenes from extracts of filamentous fungi through UV and NMR profiles. J Antibiot (Tokyo) (2010) 0.87
Thielavin B methyl ester: a cytotoxic benzoate trimer from an unidentified fungus (MSX 55526) from the Order Sordariales. Tetrahedron Lett (2011) 0.87
Potent cytotoxic arylnaphthalene lignan lactones from Phyllanthus poilanei. J Nat Prod (2014) 0.85
Constituents of an extract of Cryptocarya rubra housed in a repository with cytotoxic and glucose transport inhibitory effects. J Nat Prod (2013) 0.84
Discovery of Anticancer Agents of Diverse Natural Origin. Anticancer Res (2016) 0.83
Goyazensolide Induces Apoptosis in Cancer Cells in vitro and in vivo. Int J Cancer Res (2015) 0.83
Indole alkaloids from two cultured cyanobacteria, Westiellopsis sp. and Fischerella muscicola. Bioorg Med Chem (2012) 0.83
Predicting in silico which mixtures of the natural products of plants might most effectively kill human leukemia cells? Evid Based Complement Alternat Med (2013) 0.81
Bioactivity-guided isolation of cytotoxic sesquiterpenes of Rolandra fruticosa. Phytochemistry (2010) 0.81
Phytochemical and Bioactivity Studies on Constituents of the Leaves of Vitex Quinata. Phytochem Lett (2011) 0.81
Antitumor Effects and Related Mechanisms of Penicitrinine A, a Novel Alkaloid with a Unique Spiro Skeleton from the Marine Fungus Penicillium citrinum. Mar Drugs (2015) 0.81
Enhanced dereplication of fungal cultures via use of mass defect filtering. J Antibiot (Tokyo) (2017) 0.79
Cytotoxic and NF-kappaB inhibitory constituents of Artocarpus rigida. J Nat Prod (2010) 0.78
Investigation of Vietnamese plants for potential anticancer agents. Phytochem Rev (2014) 0.78
Isolation of Bioactive Rotenoids and Isoflavonoids from the Fruits of Millettia caerulea. Planta Med (2016) 0.77
Spiroscytalin, a new tetramic acid and other metabolites of mixed biogenesis from Scytalidium cuboideum. Tetrahedron (2015) 0.77
Synthesis and Antitumor Activity of Ellagic Acid Peracetate. ACS Med Chem Lett (2012) 0.77
Cytotoxic Barrigenol-like Triterpenoids from an Extract of Cyrilla racemiflora Housed in a Repository. J Nat Prod (2015) 0.75
Cytotoxic and natural killer cell stimulatory constituents of Phyllanthus songboiensis. Phytochemistry (2015) 0.75
Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones. Curr Med Chem (2016) 0.75
Induction of apoptosis and G2/M arrest by ampelopsin E from Dryobalanops towards triple negative breast cancer cells, MDA-MB-231. BMC Complement Altern Med (2016) 0.75
Natural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells. Curr Genomics (2017) 0.75
A cytotoxic decahydronaphthalenylpropenal derivative and tetrahydrofuran lignans from the stems of Cameraria latifolia. Tetrahedron Lett (2013) 0.75
Cardiac Glycoside Constituents of Streblus asper with Potential Antineoplastic Activity. J Nat Prod (2016) 0.75
Succinamide derivatives of melampomagnolide B and their anti-cancer activities. Bioorg Med Chem (2017) 0.75
Biodiversity hotspots for conservation priorities. Nature (2000) 102.33
The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature (2002) 18.30
Natural products as sources of new drugs over the last 25 years. J Nat Prod (2007) 13.98
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A (2003) 13.68
The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer (2006) 11.49
Global cancer statistics in the year 2000. Lancet Oncol (2001) 11.11
NF-kappa B: a lesson in family values. Cell (1995) 7.33
Lessons from natural molecules. Nature (2004) 3.95
Cyanobacterial peptides - nature's own combinatorial biosynthesis. FEMS Microbiol Rev (2006) 3.56
Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci (1995) 3.08
Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci (2003) 2.90
Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep (2008) 2.84
Estimating the size of the world's threatened flora. Science (2002) 2.59
Prospects: histone deacetylase inhibitors. J Cell Biochem (2005) 2.46
Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Invest (2008) 2.40
In vivo cultivation of tumor cells in hollow fibers. Life Sci (1995) 2.29
Nitrogen-containing metabolites from marine cyanobacteria. Alkaloids Chem Biol (2001) 2.21
Macharistol, a new cytotoxic cinnamylphenol from the stems of Machaerium aristulatum. J Nat Prod (2001) 1.97
Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep (2005) 1.82
Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy. Anticancer Agents Med Chem (2006) 1.76
Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. J Biol Chem (1998) 1.73
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med (2004) 1.70
Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J Org Chem (2004) 1.69
Bioactive compounds from cyanobacteria and microalgae: an overview. Crit Rev Biotechnol (2005) 1.67
Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J Biol Chem (2002) 1.63
Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer (1994) 1.60
Signalling into the T-cell nucleus: NFAT regulation. Cell Signal (1998) 1.58
Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal. Phytomedicine (1996) 1.56
Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Angew Chem Int Ed Engl (2007) 1.40
Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests. J Nat Prod (2002) 1.39
Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from Aglaia elliptica. Chem Biol Interact (1998) 1.35
Total synthesis of (-)-episilvestrol and (-)-silvestrol. Angew Chem Int Ed Engl (2007) 1.27
Silvestrol regulates G2/M checkpoint genes independent of p53 activity. Anticancer Res (2006) 1.26
Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7. Anticancer Res (2007) 1.23
High-throughput microcoil NMR of compound libraries using zero-dispersion segmented flow analysis. J Comb Chem (2005) 1.22
Natural products and combinatorial chemistry: back to the future. Curr Opin Chem Biol (2004) 1.22
Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells. J Biol Chem (2002) 1.21
Histone deacetylase inhibitors: latest developments, trends and prospects. Curr Med Chem Anticancer Agents (2005) 1.19
Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor model. J Natl Cancer Inst (1994) 1.14
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum. J Nat Prod (2008) 1.12
Proteasome inhibition: a novel approach to cancer therapy. Trends Mol Med (2002) 1.08
Natural products from cyanobacteria: Exploiting a new source for drug discovery. IDrugs (2006) 1.06
1H-cyclopenta[b]benzofuran lignans from Aglaia species inhibit cell proliferation and alter cell cycle distribution in human monocytic leukemia cell lines. Z Naturforsch C (1999) 1.05
Minor cytotoxic and antibacterial compounds from the rhizomes of Amomum aculeatum. Phytochemistry (2001) 1.03
Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth. J Pharmacol Exp Ther (2000) 1.03
Mother nature's combinatorial libraries; their influence on the synthesis of drugs. Curr Opin Drug Discov Devel (2002) 1.02
Cyclopentabenzofuran lignan protein synthesis inhibitors from Aglaia odorata. J Nat Prod (1996) 1.01
The hollow fiber assay: continued characterization with novel approaches. Anticancer Res (2000) 1.00
Use of COMPARE analysis to discover new natural product drugs: isolation of camptothecin and 9-methoxycamptothecin from a new source. J Nat Prod (2000) 0.99
Constituents of the Leaves and Stem Bark of Aglaia foveolata. Tetrahedron (2007) 0.98
Correlation of in vitro cytotoxicity with preclinical in vivo antitumor activity. Anticancer Res (1988) 0.98
A tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy. J Nat Prod (2004) 0.98
Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa. J Nat Prod (2004) 0.94
In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas. In Vivo (1991) 0.93
The anticancer activity of the fungal metabolite terrecyclic acid A is associated with modulation of multiple cellular stress response pathways. Mol Cancer Ther (2005) 0.91
Apoptotic anticancer effect of alvaradoin E isolated from Alvaradoa haitiensis. Anticancer Res (2005) 0.90
Relationships between inhibitory activity against a cancer cell line panel, profiles of plants collected, and compound classes isolated in an anticancer drug discovery project. Chem Biodivers (2006) 0.90
Alvaradoins A-D. Anthracenone C arabinosides from alvaradoa jamaicensis J Nat Prod (1999) 0.89
Anti-angiogenic activities of gliotoxin and its methylthioderivative, fungal metabolites. Arch Pharm Res (2001) 0.89
Dioxadispiroketal Compounds and a Potential Acyclic Precursor from Amomum aculeatum. Tetrahedron Lett (2007) 0.87
Enhanced antimalarial activity of novel synthetic aculeatin derivatives. J Med Chem (2008) 0.87
Ecology. Tropical forest diversity--the plot thickens. Science (2001) 0.86
Preclinical antitumor activity of orally administered platinum (IV) complexes. Cancer Chemother Pharmacol (1993) 0.86
New drug targets for genomic cancer therapy: successes, limitations, opportunities and future challenges. Curr Cancer Drug Targets (2001) 0.85
Activity-guided fractionation of the leaves of Ormosia sumatrana using a proteasome inhibition assay. J Nat Prod (2004) 0.84
Alvaradoins E-N, antitumor and cytotoxic anthracenone C-glycosides from the leaves of Alvaradoa haitiensis. J Nat Prod (2007) 0.83
Phytochemical studies and cytotoxicity evaluations of Colchicum tunicatum Feinbr and Colchicum hierosolymitanum Feinbr (Colchicaceae): two native Jordanian meadow saffrons. Nat Prod Res (2006) 0.83
Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil. Invest New Drugs (2008) 0.82
Biologically active compounds of fungal origin displaying antitumor activity. Acta Pol Pharm (2005) 0.78
Cryptophycin anticancer drugs revisited. ACS Chem Biol (2006) 0.78
Influence of controllable lifestyle on recent trends in specialty choice by US medical students. JAMA (2003) 14.06
Detection of microRNA expression in human peripheral blood microvesicles. PLoS One (2008) 8.04
The influence of controllable lifestyle and sex on the specialty choices of graduating U.S. medical students, 1996-2003. Acad Med (2005) 3.32
Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia. J Clin Oncol (2008) 2.79
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway. Blood (2009) 2.39
Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care-associated infections. Am J Infect Control (2008) 2.38
Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia. Blood (2008) 2.22
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition. Blood (2010) 2.07
Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology (2010) 1.92
Exaggerated sympathetic and pressor responses to handgrip exercise in older hypertensive humans: role of the muscle metaboreflex. Am J Physiol Heart Circ Physiol (2010) 1.90
The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood (2009) 1.83
A comparison of normalization techniques for microRNA microarray data. Stat Appl Genet Mol Biol (2008) 1.82
Resorcylic acid lactones with cytotoxic and NF-κB inhibitory activities and their structure-activity relationships. J Nat Prod (2011) 1.81
Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy. Anticancer Agents Med Chem (2006) 1.76
Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. Integr Cancer Ther (2007) 1.76
Antineoplastic diterpene-benzoate macrolides from the Fijian red alga Callophycus serratus. Org Lett (2005) 1.73
Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite. J Nat Prod (2011) 1.69
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood (2007) 1.69
Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J Org Chem (2004) 1.69
Identification of hepatoprotective flavonolignans from silymarin. Proc Natl Acad Sci U S A (2010) 1.67
In-hospital treatment of obstructive sleep apnea during decompensation of heart failure. Chest (2009) 1.63
Gram-scale purification of flavonolignan diastereoisomers from Silybum marianum (Milk Thistle) extract in support of preclinical in vivo studies for prostate cancer chemoprevention. Planta Med (2007) 1.61
Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res (2005) 1.61
New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid. J Nat Prod (2005) 1.59
Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum). Org Biomol Chem (2003) 1.58
Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem (2003) 1.56
Preclinical efficacy spectrum and pharmacokinetics of ixabepilone. Cancer Chemother Pharmacol (2008) 1.53
Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals. Cancer Cell (2012) 1.52
Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma. J Antibiot (Tokyo) (2011) 1.52
HiFSA fingerprinting applied to isomers with near-identical NMR spectra: the silybin/isosilybin case. J Org Chem (2013) 1.52
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood (2007) 1.51
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection. Arch Intern Med (2003) 1.51
Bioactive 5,6-dihydro-alpha-pyrone derivatives from Hyptis brevipes. J Nat Prod (2009) 1.48
Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause (2009) 1.45
Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity. Cancer Res (2006) 1.45
A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFalpha signaling pathways. Chem Biol (2007) 1.44
Bromophycolides C-I from the Fijian red alga Callophycus serratus. J Nat Prod (2006) 1.43
Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection. Gastroenterology (2009) 1.40
Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests. J Nat Prod (2002) 1.39
Transtheoretical model-chronic disease care for obesity in primary care: a randomized trial. Obes Res (2005) 1.38
Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua. J Nat Prod (2009) 1.36
Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J Agric Food Chem (2005) 1.32
Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027. J Neurosci (2012) 1.31
Callophycoic acids and callophycols from the Fijian red alga Callophycus serratus. J Org Chem (2007) 1.29
Ponapensin, a cyclopenta[bc]benzopyran with potent NF-kappaB inhibitory activity from Aglaia ponapensis. Bioorg Med Chem Lett (2006) 1.28
Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A (2006) 1.27
Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. Cancer Res (2006) 1.27
Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation. PLoS One (2011) 1.27
Camptothecin and taxol: historic achievements in natural products research. J Nat Prod (2004) 1.26
Silvestrol regulates G2/M checkpoint genes independent of p53 activity. Anticancer Res (2006) 1.26
Isolation, structure elucidation, and absolute configuration of 26-deoxyactein from Cimicifuga racemosa and clarification of nomenclature associated with 27-deoxyactein. J Nat Prod (2002) 1.26
ASHP statement on the use of dietary supplements. Am J Health Syst Pharm (2004) 1.26
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody. Blood (2009) 1.25
IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production. J Immunol (2011) 1.25
Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol (2010) 1.24
Estrogens and congeners from spent hops (Humulus lupulus). J Nat Prod (2004) 1.24
Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae. J Antibiot (Tokyo) (2012) 1.24
Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer. Invest Radiol (2009) 1.24
Bioactive constituents of the stem bark of Mitrephora glabra. J Nat Prod (2009) 1.23
Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7. Anticancer Res (2007) 1.23
Serotonergic activity-guided phytochemical investigation of the roots of Angelica sinensis. J Nat Prod (2006) 1.23
Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re-collection of Aglaia foveolata. J Nat Prod (2010) 1.23
Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. Circulation (2008) 1.23
The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J Clin Endocrinol Metab (2010) 1.22
Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations. J Pharmacol Exp Ther (2009) 1.21
Effectiveness of a postdischarge care management model for stroke and transient ischemic attack: a randomized trial. J Stroke Cerebrovasc Dis (2007) 1.20
Xanthohumol isolated from Humulus lupulus Inhibits menadione-induced DNA damage through induction of quinone reductase. Chem Res Toxicol (2005) 1.20
Effectiveness of a group exercise program in a long-term care facility: a randomized pilot trial. J Am Med Dir Assoc (2003) 1.20
Preclinical discovery of ixabepilone, a highly active antineoplastic agent. Cancer Chemother Pharmacol (2008) 1.19
Antimalarial bromophycolides J-Q from the Fijian red alga Callophycus serratus. J Org Chem (2009) 1.19